🇺🇸 FDA
Pipeline program

Telaprevir

VX11-950-114

Phase 3 small_molecule terminated

Quick answer

Telaprevir for Hepatitis C, Chronic is a Phase 3 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 2 ClinicalTrials.gov record(s).

Program details

Company
VERTEX PHARMACEUTICALS INC / MA
Indication
Hepatitis C, Chronic
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials